The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cancer Diagnostics Device Market Research Report 2024
Synopsis
Diagnostic testing involves tests and procedures to confirm the presence of disease and identify the correct tumor type, location, extent and stage.
The global Cancer Diagnostics Device market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Cancer Diagnostics Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Diagnostics Device.
Report Scope
The Cancer Diagnostics Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cancer Diagnostics Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Diagnostics Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Diagnostics
Agilent Technologies
BD
bioMérieux
Qiagen
Roche Diagnostics
Segment by Type
Companion Diagnostics
Molecular Diagnostics
Segment by Application
Lung
Breast
Colorectal
Prostate
Cervical
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cancer Diagnostics Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cancer Diagnostics Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Diagnostic testing involves tests and procedures to confirm the presence of disease and identify the correct tumor type, location, extent and stage.
The global Cancer Diagnostics Device market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Cancer Diagnostics Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Diagnostics Device.
Report Scope
The Cancer Diagnostics Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cancer Diagnostics Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Diagnostics Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Diagnostics
Agilent Technologies
BD
bioMérieux
Qiagen
Roche Diagnostics
Segment by Type
Companion Diagnostics
Molecular Diagnostics
Segment by Application
Lung
Breast
Colorectal
Prostate
Cervical
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cancer Diagnostics Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cancer Diagnostics Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Cancer Diagnostics Device Market Overview
1.1 Product Overview and Scope of Cancer Diagnostics Device
1.2 Cancer Diagnostics Device Segment by Type
1.2.1 Global Cancer Diagnostics Device Market Value Comparison by Type (2024-2030)
1.2.2 Companion Diagnostics
1.2.3 Molecular Diagnostics
1.3 Cancer Diagnostics Device Segment by Application
1.3.1 Global Cancer Diagnostics Device Market Value by Application: (2024-2030)
1.3.2 Lung
1.3.3 Breast
1.3.4 Colorectal
1.3.5 Prostate
1.3.6 Cervical
1.3.7 Others
1.4 Global Cancer Diagnostics Device Market Size Estimates and Forecasts
1.4.1 Global Cancer Diagnostics Device Revenue 2019-2030
1.4.2 Global Cancer Diagnostics Device Sales 2019-2030
1.4.3 Global Cancer Diagnostics Device Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Cancer Diagnostics Device Market Competition by Manufacturers
2.1 Global Cancer Diagnostics Device Sales Market Share by Manufacturers (2019-2024)
2.2 Global Cancer Diagnostics Device Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Cancer Diagnostics Device Average Price by Manufacturers (2019-2024)
2.4 Global Cancer Diagnostics Device Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cancer Diagnostics Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cancer Diagnostics Device, Product Type & Application
2.7 Cancer Diagnostics Device Market Competitive Situation and Trends
2.7.1 Cancer Diagnostics Device Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Cancer Diagnostics Device Players Market Share by Revenue
2.7.3 Global Cancer Diagnostics Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cancer Diagnostics Device Retrospective Market Scenario by Region
3.1 Global Cancer Diagnostics Device Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Cancer Diagnostics Device Global Cancer Diagnostics Device Sales by Region: 2019-2030
3.2.1 Global Cancer Diagnostics Device Sales by Region: 2019-2024
3.2.2 Global Cancer Diagnostics Device Sales by Region: 2025-2030
3.3 Global Cancer Diagnostics Device Global Cancer Diagnostics Device Revenue by Region: 2019-2030
3.3.1 Global Cancer Diagnostics Device Revenue by Region: 2019-2024
3.3.2 Global Cancer Diagnostics Device Revenue by Region: 2025-2030
3.4 North America Cancer Diagnostics Device Market Facts & Figures by Country
3.4.1 North America Cancer Diagnostics Device Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Cancer Diagnostics Device Sales by Country (2019-2030)
3.4.3 North America Cancer Diagnostics Device Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Cancer Diagnostics Device Market Facts & Figures by Country
3.5.1 Europe Cancer Diagnostics Device Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Cancer Diagnostics Device Sales by Country (2019-2030)
3.5.3 Europe Cancer Diagnostics Device Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cancer Diagnostics Device Market Facts & Figures by Country
3.6.1 Asia Pacific Cancer Diagnostics Device Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Cancer Diagnostics Device Sales by Country (2019-2030)
3.6.3 Asia Pacific Cancer Diagnostics Device Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Cancer Diagnostics Device Market Facts & Figures by Country
3.7.1 Latin America Cancer Diagnostics Device Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Cancer Diagnostics Device Sales by Country (2019-2030)
3.7.3 Latin America Cancer Diagnostics Device Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cancer Diagnostics Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Cancer Diagnostics Device Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Cancer Diagnostics Device Sales by Country (2019-2030)
3.8.3 Middle East and Africa Cancer Diagnostics Device Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Cancer Diagnostics Device Sales by Type (2019-2030)
4.1.1 Global Cancer Diagnostics Device Sales by Type (2019-2024)
4.1.2 Global Cancer Diagnostics Device Sales by Type (2025-2030)
4.1.3 Global Cancer Diagnostics Device Sales Market Share by Type (2019-2030)
4.2 Global Cancer Diagnostics Device Revenue by Type (2019-2030)
4.2.1 Global Cancer Diagnostics Device Revenue by Type (2019-2024)
4.2.2 Global Cancer Diagnostics Device Revenue by Type (2025-2030)
4.2.3 Global Cancer Diagnostics Device Revenue Market Share by Type (2019-2030)
4.3 Global Cancer Diagnostics Device Price by Type (2019-2030)
5 Segment by Application
5.1 Global Cancer Diagnostics Device Sales by Application (2019-2030)
5.1.1 Global Cancer Diagnostics Device Sales by Application (2019-2024)
5.1.2 Global Cancer Diagnostics Device Sales by Application (2025-2030)
5.1.3 Global Cancer Diagnostics Device Sales Market Share by Application (2019-2030)
5.2 Global Cancer Diagnostics Device Revenue by Application (2019-2030)
5.2.1 Global Cancer Diagnostics Device Revenue by Application (2019-2024)
5.2.2 Global Cancer Diagnostics Device Revenue by Application (2025-2030)
5.2.3 Global Cancer Diagnostics Device Revenue Market Share by Application (2019-2030)
5.3 Global Cancer Diagnostics Device Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abbott Diagnostics
6.1.1 Abbott Diagnostics Corporation Information
6.1.2 Abbott Diagnostics Description and Business Overview
6.1.3 Abbott Diagnostics Cancer Diagnostics Device Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abbott Diagnostics Cancer Diagnostics Device Product Portfolio
6.1.5 Abbott Diagnostics Recent Developments/Updates
6.2 Agilent Technologies
6.2.1 Agilent Technologies Corporation Information
6.2.2 Agilent Technologies Description and Business Overview
6.2.3 Agilent Technologies Cancer Diagnostics Device Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Agilent Technologies Cancer Diagnostics Device Product Portfolio
6.2.5 Agilent Technologies Recent Developments/Updates
6.3 BD
6.3.1 BD Corporation Information
6.3.2 BD Description and Business Overview
6.3.3 BD Cancer Diagnostics Device Sales, Revenue and Gross Margin (2019-2024)
6.3.4 BD Cancer Diagnostics Device Product Portfolio
6.3.5 BD Recent Developments/Updates
6.4 bioMérieux
6.4.1 bioMérieux Corporation Information
6.4.2 bioMérieux Description and Business Overview
6.4.3 bioMérieux Cancer Diagnostics Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 bioMérieux Cancer Diagnostics Device Product Portfolio
6.4.5 bioMérieux Recent Developments/Updates
6.5 Qiagen
6.5.1 Qiagen Corporation Information
6.5.2 Qiagen Description and Business Overview
6.5.3 Qiagen Cancer Diagnostics Device Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Qiagen Cancer Diagnostics Device Product Portfolio
6.5.5 Qiagen Recent Developments/Updates
6.6 Roche Diagnostics
6.6.1 Roche Diagnostics Corporation Information
6.6.2 Roche Diagnostics Description and Business Overview
6.6.3 Roche Diagnostics Cancer Diagnostics Device Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Roche Diagnostics Cancer Diagnostics Device Product Portfolio
6.6.5 Roche Diagnostics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cancer Diagnostics Device Industry Chain Analysis
7.2 Cancer Diagnostics Device Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cancer Diagnostics Device Production Mode & Process
7.4 Cancer Diagnostics Device Sales and Marketing
7.4.1 Cancer Diagnostics Device Sales Channels
7.4.2 Cancer Diagnostics Device Distributors
7.5 Cancer Diagnostics Device Customers
8 Cancer Diagnostics Device Market Dynamics
8.1 Cancer Diagnostics Device Industry Trends
8.2 Cancer Diagnostics Device Market Drivers
8.3 Cancer Diagnostics Device Market Challenges
8.4 Cancer Diagnostics Device Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
